Health for body and mind
Ubiquinol and Glavonoid™ offer natural efficacy and safety
Brussels (Belgium), December 2014 – Kaneka Pharma Europe highlighted on HiE Amsterdam functional ingredients well backed by science. The focus was on the naturally produced ingredients Ubiquinol and Glavonoid™. Ubiquinol, the active form of coenzyme Q10 with higher bioavailability, is essential for the body’s energy production and furthermore protects cells from oxidative damage. The licorice extract Glavonoid™ helps to reduce visceral fat. Both substances can be used in single ingredient supplement applications as well as in functional food combinations.
Ubiquinol is found in every human cell and is an essential part of the respiratory chain, which produces more than 95 percent of the energy the body needs to sustain its vital functions. It is also a naturally occurring lipid soluble antioxidant that counteracts the aging process and protects cells from free radical damage. Ubiquinol is therefore crucial for a healthy body and high level performance – mentally as well as physically. Due to its high bioavailability and its ready-to-use form, Ubiquinol has a more rapid and better effect than coenzyme Q10, which has to be converted by the body before it can be used. Filip Van hulle, Sales and Marketing Manager at Kaneka Pharma Europe, commented: “In our opinion, the market potential for products containing functional ingredients such as Ubiquinol and Glavonoid™ is huge, as they are backed by numerous scientific studies and offer a variety of health benefits.” One example is Ubiquinol Omega-3 Aktiv-Formula capsules from the German company Biogenial. These have been inspired by findings that Inuit, whose natural diet is rich in Omega-3 fatty acids as well as coenzyme Q10, have a low prevalence of heart disease. By combining omega-3 fatty acids of marine origin and Ubiquinol, the capsules can contribute to the normal function of the heart. Kaneka QH™ Ubiquinol is suitable for use in soft gel capsules, pellets and sticks, as well as in foodstuffs.
Kaneka was also presenting its Novel Food-approved licorice extract Glavonoid™. Because of its patented manufacturing process, the extract is free from glycyrrhizinic acid and therefore free from any associated cortisone-like side effects. Glavonoid™ offers a unique dual action in fighting visceral fat, thanks to its ability to activate the body’s fat metabolism and suppress fat synthesis. Studies have demonstrated that an intake of 100 mg Glavonoid™ per day burns 130 kcal of body fat. The extract can be processed in food supplements and beverages. Suitable for all kinds of weight management products, it can also be included in products aimed at the sports and fitness market, as well as healthy aging.
About Kaneka Pharma Europe
Kaneka Pharma Europe is based in Brussels. It is a full subsidiary of Kaneka Japan, the world’s leading supplier of coenzyme Q10 and the only supplier of Ubiquinol (the active form of coenzyme Q10).
Kaneka was founded in 1949 and is the only company to use natural yeast fermentation technology to produce coenzyme Q10. Kaneka Q10™ is the only self-affirmed GRAS coenzyme Q10 and can be globally sourced from two production sites in the US and Japan, as well as from Kaneka’s warehouses in Brussels.
Kaneka also developed the licorice root extract Glavonoid™, which supports the reduction of visceral fat. With Novel Food approval having been granted in November 2011, the first products are now available on the European market.
Kaneka’s company philosophy is based on a strong scientific grounding. Accordingly, the efficacy and safety of Kaneka Q10™, Ubiquinol and Glavonoid™ are well proven, and backed by a large number of scientific studies.
For further information, please visit:
www.ubiquinol.org www.KanekaQ10.info
Company Contact
KANEKA PHARMA EUROPE N.V.
Filip Van hulle
Sales and Marketing Manager
Triomflaan 173
1160 Brussels
Belgium
Tel + 32 2 663 03 48
Fax + 32 2 663 03 61
Filip.VanHulle@kaneka.be
Press Contact
akp public relations
Christina Fahrtmann
Tannenstraße 1a
69469 Weinheim
Germany
Tel: +49 6201 188 98 10
Fax: +49 6201 188 98 20
fahrtmann@akp-pr.de
